- Sport Sciences - Apr 17 Toronto 2015 Pan Am/Parapan Am Games: the science of sprinting
- Medicine - Apr 17 Statement from U of M president following New York Times story
- Medicine - Apr 17 New developments in Midwestern canine influenza outbreak
- Medicine - Apr 17 Chancellor Michael Wilson named chair of Mental Health Commission of Canada
- Environmental Sciences - Apr 17 Fast access to CryoSat’s Arctic ice measurements now available
- Event - Apr 17 Children with disabilities can make competent witnesses
- Psychology - Apr 17 Leaders who can read the crowd do better
- Social Sciences - Apr 17 Victorian youth re-offending rates significantly lower than today
- Medicine - Apr 17 Cognitive problems are common after cardiac arrest
- Social Sciences - Apr 17 Manifesto Check: Conservatives talk tough but bring nothing new on immigration
- Arts - Apr 17 Thumbnail track pad
- Medicine - Apr 16 Sandoz receives FDA approval for GlatopaTM as the first generic competitor to MS therapy Copaxone 20mg
- Social Sciences - Apr 16 Manifesto Check: on immigration, UKIP offers only confusion
- Chemistry - Apr 16 Scientists collaborate on project to make next generation industrial filters
- Medicine - Apr 16 Victorian baby teeth could help predict future health of children today
- Astronomy - Apr 16 GOCE helps tap into sustainable energy resources
Stopping cell migration may help block fibrosis and the spread of cancer
Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration. The study appears in the Advance Online Publication of Nature Cell Biology.
Pulmonary fibrosis is the development of excessive connective tissue in the lungs. It can develop without a known cause, and produces permanent scar tissue in the lungs. There is no known cure or treatment to slow down its progress.
Cell migration is the biological process by which cells move around the body, often contributing to the development or spread of diseases such as fibrosis or metastatic cancer.
Fibroblast connective tissue cells and cancer cells migrate in a way that requires sustained activation of signaling pathways. But until now the regulation of these cellular functions has been poorly understood. The Yale team studied the workings of a stimulant of cell migration known as lysophosphatidic acid (LPA). They identified the chemical reactions that ultimately induce cell migration, but more importantly, discovered a way to block the pathway via inhibition of the proteins responsible for promoting the migration.
Senior author Dianqing (Dan) Wu, professor of pharmacology and vascular biology at Yale School of Medicine and member of Yale Cancer Center, explained, "Our ability to block the pathway provides a potential therapeutic target for treating pulmonary fibrosis, a very serious disease that lacks effective treatments, and other types of fibrosis. Because cancer cells, particularly melanoma and lung cancer cells containing activated BRAF genetic mutations, can use this signaling pathway to migrate, blocking this pathway could also prevent metastasis of these cancers."
Other authors are Xiaoqing Gan, Jiyong Wang and Chen Wang of Yale; Eeva Sommer and Dario Alessi of the University of Dundee; Tohru Kozasa of the University of Illinois at Chicago; Srinivasa Srinivasula of the National Cancer Institute; Stefan Offermanns of the Max-Planck-Institute for Heart and Lung Research; and Melvin I. Simon of the University of California at San Diego.
Last job offers
- Pedagogy/Education Science - 17.4
- Social Sciences - 17.4
Wissensch. Mitarbeiter/in (80 %) Übergänge Schule – Beruf – Selbständige Lebensführung
- Medicine/Pharmacology - 15.4
Wissensch. Mitarbeiter/in Naturwissenschaftsdidaktik (40−50 %)
- Business/Economics - 13.4
EPFL / Schweizerische Post: Doktorandenstelle zum Thema “Bargeldentwicklung 202X”
- Architecture - 9.4
Professeur-e HES - Responsable de son Département Architecture d’intérieur
- Mathematics - 7.4
Dozent/in (60–80 %) Fachwissenschaft Mathematik
- Event - 17.4
Professor II/førsteamanuensis 20% i medisin (helsefag) knyttet til hovedstilling ved Regionsenter for...
- Administration/Government - 17.4
Professor/førsteamanuensis i skatterett
- Chemistry - 17.4
Professur für Chemische Verfahrenstechnik
- Business/Economics - 15.4
Universitätsassistentin mit Doktorat für Professoren-Laufbahnstelle
- Mechanical Engineering - 17.4
- Media Sciences - 17.4
Professur für Europäische Politik
- Medicine/Pharmacology - 17.4
Lecturer (Grade 8) or Associate Professor (Grade 9) in decision-analytic modelling for economic evaluations...
- Media Sciences - 17.4
Chair in Political Science / International Studies- 31505
- Life Sciences - 18.4
Faculty Position in Surgical Pathology
- Life Sciences - 17.4
Assistant / Associate Professor of Genetics and Complex Diseases